Surgical Management of Parkinson's Disease: Update and Review

• Published in: Interventional neuroradiology Vol. 13; no. 4; pp. 359 - 368
• Main Authors: Chao, Y., Gang, L., Na, Z.L., Ming, W.Y., Zhong, W.S., Mian, W.S.
• Format: Journal Article
• Language: English
• Published: London, England SAGE Publications 01.12.2007; Centauro S.r.l
• Subjects: Original; cell transplantation; Parkinson's disease; internal globus pallidus; gene therapy; subthalamus; deep brain stimulation; ablative surgery; thalamus
• ISSN: 1591-0199; 2385-2011
• DOI: 10.1177/159101990701300407

Although medical therapy is still the mainstay of treatment for Parkinson's disease, the development of surgical precision and decreased morbidity have made stereotatic lesioning and deep brain stimulation more popular. Neurosurgical ablations include pallidotomy, thalamotomy, and, more recently, subthalamotomy. Because of concern over the high risk of side-effects resulting from bilateral ablative procedure, alternative approaches have been explored. With improved deep brain stimulation (DBS) technology, DBS has been successfully applied in the internal globus pallidus, ventral intermediate nucleus and subthalamic nucleus for Parkinson's disease. In addition, recent surgical approaches including biological neurorestorative technologies — surgical therapies with transplantation, gene therapy, and growth factor are all being discussed in this review. Although a great deal of work remains to be done for researchers, advances in surgical therapies for the treatment of Parkinson's disease are moving forward at an unprecedented pace, and, not surprisingly, would give PD patients more choices and hope.